2.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IOVA Giù?
Forum
Previsione
Frazionamento azionario
Iovance Biotherapeutics Inc Azioni (IOVA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
21.55%
59.95
|
49.32 | 58.55 | 31.11 | 0.715 |
Cost Of Revenue |
13.92%
56.66
|
49.74 | 39.82 | 31.37 | 7.261 |
Gross Profit |
888.49%
3.288
|
-0.417 | 18.73 | -0.262 | -6.546 |
|
3.10%
117.06
|
120.80 | 107.80 | 101.65 | 111.18 |
Benefits Costs and Expenses |
1.37%
169.62
|
167.32 | 143.62 | 129.66 | 115.10 |
Costs And Expenses |
1.87%
173.73
|
170.54 | 147.62 | 133.02 | 118.44 |
Operating Income/Loss |
6.14%
-113.77
|
-121.22 | -89.07 | -101.91 | -117.72 |
Income/Loss From Continuing Operations Before Tax |
7.06%
-109.67
|
-118.00 | -85.06 | -98.56 | -114.38 |
Income Tax Expense/Benefit, Deferred |
208.16%
1.988
|
-1.838 | -1.521 | -1.458 | -1.408 |
Income Tax Expense/Benefit |
208.16%
1.988
|
-1.838 | -1.52 | -1.458 | -1.408 |
Income/Loss From Continuing Operations After Tax |
3.88%
-111.66
|
-116.16 | -83.54 | -97.10 | -112.98 |
|
3.88%
-111.66
|
-116.16 | -83.54 | -97.10 | -112.98 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3.61%
0.3345
|
0.3229 | 0.3033 | 0.2848 | 266.22 |
Diluted Average Shares |
3.61%
0.3345
|
0.3229 | 0.3033 | 0.2848 | 266.22 |
Basic Earnings Per Share |
8.33%
-0.33
|
-0.36 | -0.28 | -0.34 | -0.42 |
Diluted Earnings Per Share |
8.33%
-0.33
|
-0.36 | -0.28 | -0.34 | -0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):